Detalhe da pesquisa
1.
Combination of pembrolizumab and pelareorep promotes anti-tumour immunity in advanced pancreatic adenocarcinoma (PDAC).
Br J Cancer;
129(5): 782-790, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37443348
2.
The differential expression of toll like receptors and RIG-1 correlates to the severity of infectious diseases.
Ann Diagn Pathol;
63: 152102, 2023 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36634551
3.
GOBLET: a phase I/II study of pelareorep and atezolizumab +/- chemo in advanced or metastatic gastrointestinal cancers.
Future Oncol;
18(26): 2871-2878, 2022 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35796248
4.
Exploring traditional and nontraditional roles for thrombomodulin.
Blood;
132(2): 148-158, 2018 07 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29866818
5.
Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell-Based Immunotherapies.
Cancer Immunol Res;
12(3): 334-349, 2024 03 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38194598
6.
Oncolytic virus-mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice.
Sci Transl Med;
14(640): eabn2231, 2022 04 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35417192
7.
CD248 enhances tissue factor procoagulant function, promoting arterial and venous thrombosis in mouse models.
J Thromb Haemost;
19(8): 1932-1947, 2021 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33830628